Clinical Trials Logo

Prostate Cancer clinical trials

View clinical trials related to Prostate Cancer.

Filter by:
  • Withdrawn  
  • Page 1 ·  Next »

NCT ID: NCT03035357 Withdrawn - Prostate Cancer Clinical Trials

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Start date: March 1, 2017
Phase: Phase 2
Study type: Interventional

The goal of this clinical research study is to learn about biomarker changes in patients who have primary prostate cancer after receiving Darzalex (daratumumab) and then have a prostatectomy (the surgical removal of the prostate) as part of their standard care. Biomarkers are found in the blood/tissue and may be related to your reaction to the study drug.

NCT ID: NCT02678520 Withdrawn - Prostate Cancer Clinical Trials

Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients

Start date: December 2015
Phase: Phase 2
Study type: Interventional

Compare the incidence of acute rectal, bladder and other acute toxicities between 3-D Conformal Radiation Therapy (RT/CRT) and Intensity Modulated Radiation Therapy (IMRT) in Post-Prostatectomy Prostate Cancer Patients treated with post-operative radiation therapy

NCT ID: NCT02656563 Withdrawn - Prostate Cancer Clinical Trials

Radium 223 Following Intermittent ADT

RAND
Start date: October 2015
Phase: Phase 2
Study type: Interventional

This is a multicentre, phase II, randomized, open label study to evaluate the efficacy and safety of monthly Radium 223 in prolonging the off treatment interval of men with localized prostate cancer receiving intermittent androgen ablation therapy for a rising PSA post-radiation or post-prostatectomy, who are at high risk for occult metastases.

NCT ID: NCT02645591 Withdrawn - Prostate Cancer Clinical Trials

Randomized AmnioFix Study During Radical Prostatectomy

Start date: November 2016
Phase: Phase 2
Study type: Interventional

The goal of this clinical research study is to learn about the safety and the effectiveness of using AmnioFix® (dehydrated human amnion/chorion membrane, also called dHACM) to help improve the return of erectile function and bladder control in patients after robotic assisted laparoscopic radical prostatectomy (RARP). dHACM is a section of tissue made from part of the placenta donated by a mother during a C-section. It looks like a small piece of tissue paper and is wrapped around the nerve bundles in the surgical area. The tissue may help the body's normal healing process.

NCT ID: NCT02621684 Withdrawn - Prostate Cancer Clinical Trials

Physical Activity Intervention in African American Men After Radical Prostatectomy

Start date: November 2014
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to evaluate the feasibility of recruiting African American prostate cancer survivors to a 12 week physical activity intervention study of three arms (aerobics, resistance training, and usual care) through physician referral and community advertisement strategies. In addition, the investigators will investigate the acceptance rate of the intervention and gather preliminary results on the effect of exercise on African American men's urinary and sexual functions. These data can then be used to refine the intervention and its implementation model, and to inform the submission of a larger grant to the National Institutes of Health.

NCT ID: NCT02538432 Withdrawn - Breast Cancer Clinical Trials

Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors

Start date: June 2017
Phase: Phase 2
Study type: Interventional

This is a phase II trial of (RQ-07) in advanced solid tumors in prostate, breast or non-small cell lung cancer.

NCT ID: NCT02512120 Withdrawn - Prostate Cancer Clinical Trials

Volume Controlled Ventilation vs Autoflow-volume Controlled Ventilation

VCVAFVCV
Start date: August 2015
Phase: N/A
Study type: Interventional

Volume controlled ventilation(VCV) is a most common used ventilation mode during general anesthesia. But VCV can cause high airway peak pressure when patient under steep Trendelenberg position with pneumoperitoneum. Autoflow-VCV can reduce airway peak pressure and improve dynamic compliance. We will compare parameters(arterial blood gas analysis, airway compliance, etc) when each group applied VCV and autoflow-VCV during RALP.

NCT ID: NCT02424513 Withdrawn - Prostate Cancer Clinical Trials

A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer

Start date: March 2015
Phase: Phase 2
Study type: Interventional

This is a prospective, multicenter, open-label, non-randomized study evaluating the ability of [89]Zr-Df-IAb2M to detect local, regional and metastatic prostate cancer confirmed by pathology.

NCT ID: NCT02420587 Withdrawn - Prostate Cancer Clinical Trials

AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Start date: October 2014
Phase: Phase 2
Study type: Interventional

The goal of this clinical research study is learn how AMG208 may help to control prostate cancer that has spread to the bone. The safety of the drug will also be studied.

NCT ID: NCT02396368 Withdrawn - Prostate Cancer Clinical Trials

A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer

Radium-223
Start date: March 2015
Phase: Phase 1
Study type: Interventional

This is a Phase I/Ib study of Radium-223 in combination with Tasquinimod for patients with bone metastases from castration-resistant prostate cancer (CRPC). The investigators propose to determine the spectrum of tolerability of the combination of tasquinimod and radium-223 and determine a dose for a subsequent randomized phase II study (first cohort) and the proportion of men with bone-specific alkaline phosphatase response (second cohort).